SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001214659-23-015549
Filing Date
2023-11-24
Accepted
2023-11-24 13:49:31
Documents
2
Group Members
KEVIN TANGTANG CAPITAL MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 p1116235sc13g.htm SC 13G 82686
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 7772
  Complete submission text file 0001214659-23-015549.txt   92031
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL PARTNERS LP (Filed by) CIK: 0001191935 (see all company filings)

IRS No.: 680517277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Subject) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89137 | Film No.: 231436388
SIC: 2834 Pharmaceutical Preparations